The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Liver Cirrhosis Treatment Market Research Report 2025

Global Liver Cirrhosis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1675842

No of Pages : 83

Ask Your Query

Liver cirrhosis treatment refers to the medical approaches, interventions, and strategies aimed at managing and slowing down the progression of cirrhosis, a chronic and irreversible condition characterized by the gradual replacement of healthy liver tissue with scar tissue. The primary goals of liver cirrhosis treatment are to prevent further liver damage, alleviate symptoms, manage complications, and improve the quality of life for individuals affected by this condition.

Global Liver Cirrhosis Treatment market is projected to reach US$ 16680 million in 2029, increasing from US$ 8701.4 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2029.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Liver Cirrhosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Pfizer
  •     Abbott Laboratories
  •     Merck & Co., Inc.
  •     Novartis AG
  •     F. Hoffmann-La Roche
  •     Takeda Pharmaceuticals Company
  •     Zydus Pharmaceuticals

Segment by Type

  •     Operation Treatment
  •     Medical Treatement

Segment by Application

  •     Alcoholic Cirrhosis
  •     Atrophic Liver Cirrhosis
  •     Biliary Cirrhosis
  •     Cryptogenic Cirrhosis

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Liver Cirrhosis Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Liver Cirrhosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Operation Treatment
        1.2.3 Medical Treatement
    1.3 Market by Application
        1.3.1 Global Liver Cirrhosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Alcoholic Cirrhosis
        1.3.3 Atrophic Liver Cirrhosis
        1.3.4 Biliary Cirrhosis
        1.3.5 Cryptogenic Cirrhosis
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Liver Cirrhosis Treatment Market Perspective (2018-2029)
    2.2 Liver Cirrhosis Treatment Growth Trends by Region
        2.2.1 Global Liver Cirrhosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Liver Cirrhosis Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Liver Cirrhosis Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Liver Cirrhosis Treatment Market Dynamics
        2.3.1 Liver Cirrhosis Treatment Industry Trends
        2.3.2 Liver Cirrhosis Treatment Market Drivers
        2.3.3 Liver Cirrhosis Treatment Market Challenges
        2.3.4 Liver Cirrhosis Treatment Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Liver Cirrhosis Treatment Players by Revenue
        3.1.1 Global Top Liver Cirrhosis Treatment Players by Revenue (2018-2023)
        3.1.2 Global Liver Cirrhosis Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Liver Cirrhosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Liver Cirrhosis Treatment Revenue
    3.4 Global Liver Cirrhosis Treatment Market Concentration Ratio
        3.4.1 Global Liver Cirrhosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Liver Cirrhosis Treatment Revenue in 2022
    3.5 Liver Cirrhosis Treatment Key Players Head office and Area Served
    3.6 Key Players Liver Cirrhosis Treatment Product Solution and Service
    3.7 Date of Enter into Liver Cirrhosis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Liver Cirrhosis Treatment Breakdown Data by Type
    4.1 Global Liver Cirrhosis Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Liver Cirrhosis Treatment Forecasted Market Size by Type (2024-2029)

 5 Liver Cirrhosis Treatment Breakdown Data by Application
    5.1 Global Liver Cirrhosis Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Liver Cirrhosis Treatment Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Liver Cirrhosis Treatment Market Size (2018-2029)
    6.2 North America Liver Cirrhosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Liver Cirrhosis Treatment Market Size by Country (2018-2023)
    6.4 North America Liver Cirrhosis Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Liver Cirrhosis Treatment Market Size (2018-2029)
    7.2 Europe Liver Cirrhosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Liver Cirrhosis Treatment Market Size by Country (2018-2023)
    7.4 Europe Liver Cirrhosis Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Liver Cirrhosis Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Liver Cirrhosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Liver Cirrhosis Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Liver Cirrhosis Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Liver Cirrhosis Treatment Market Size (2018-2029)
    9.2 Latin America Liver Cirrhosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Liver Cirrhosis Treatment Market Size by Country (2018-2023)
    9.4 Latin America Liver Cirrhosis Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Liver Cirrhosis Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Liver Cirrhosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Liver Cirrhosis Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Liver Cirrhosis Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Liver Cirrhosis Treatment Introduction
        11.1.4 Pfizer Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.1.5 Pfizer Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Detail
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories Liver Cirrhosis Treatment Introduction
        11.2.4 Abbott Laboratories Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.2.5 Abbott Laboratories Recent Development
    11.3 Merck & Co., Inc.
        11.3.1 Merck & Co., Inc. Company Detail
        11.3.2 Merck & Co., Inc. Business Overview
        11.3.3 Merck & Co., Inc. Liver Cirrhosis Treatment Introduction
        11.3.4 Merck & Co., Inc. Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.3.5 Merck & Co., Inc. Recent Development
    11.4 Novartis AG
        11.4.1 Novartis AG Company Detail
        11.4.2 Novartis AG Business Overview
        11.4.3 Novartis AG Liver Cirrhosis Treatment Introduction
        11.4.4 Novartis AG Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.4.5 Novartis AG Recent Development
    11.5 F. Hoffmann-La Roche
        11.5.1 F. Hoffmann-La Roche Company Detail
        11.5.2 F. Hoffmann-La Roche Business Overview
        11.5.3 F. Hoffmann-La Roche Liver Cirrhosis Treatment Introduction
        11.5.4 F. Hoffmann-La Roche Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.5.5 F. Hoffmann-La Roche Recent Development
    11.6 Takeda Pharmaceuticals Company
        11.6.1 Takeda Pharmaceuticals Company Company Detail
        11.6.2 Takeda Pharmaceuticals Company Business Overview
        11.6.3 Takeda Pharmaceuticals Company Liver Cirrhosis Treatment Introduction
        11.6.4 Takeda Pharmaceuticals Company Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.6.5 Takeda Pharmaceuticals Company Recent Development
    11.7 Zydus Pharmaceuticals
        11.7.1 Zydus Pharmaceuticals Company Detail
        11.7.2 Zydus Pharmaceuticals Business Overview
        11.7.3 Zydus Pharmaceuticals Liver Cirrhosis Treatment Introduction
        11.7.4 Zydus Pharmaceuticals Revenue in Liver Cirrhosis Treatment Business (2018-2023)
        11.7.5 Zydus Pharmaceuticals Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock